It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lower extremity lymphedema (LEL) is a common complication after gynecological cancer treatment, which significantly reduces the quality of life. While early diagnosis and intervention can prevent severe complications, there is currently no consensus on the optimal screening strategy for postoperative LEL. In this study, we developed a computer-aided diagnosis (CAD) software for LEL screening in pelvic computed tomography (CT) images using deep learning. A total of 431 pelvic CT scans from 154 gynecological cancer patients were used for this study. We employed ResNet-18, ResNet-34, and ResNet-50 models as the convolutional neural network (CNN) architecture. The input image for the CNN model used a single CT image at the greater trochanter level. Fat-enhanced images were created and used as input to improve classification performance. Receiver operating characteristic analysis was used to evaluate our method. The ResNet-34 model with fat-enhanced images achieved the highest area under the curve of 0.967 and an accuracy of 92.9%. Our CAD software enables LEL diagnosis from a single CT image, demonstrating the feasibility of LEL screening only on CT images after gynecologic cancer treatment. To increase the usefulness of our CAD software, we plan to validate it using external datasets.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Chiba University, Center for Frontier Medical Engineering, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
2 Chiba University, Department of Medical Engineering, Faculty of Engineering, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
3 Chiba University, Department of Plastic, Reconstructive and Aesthetic Surgery, Graduate School of Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
4 Saiseikai Yokohamashi Nanbu Hospital, Department of Plastic Surgery, Yokohama City, Japan (GRID:grid.136304.3)
5 Chiba University Hospital, Department of Gynecology and Maternal-Fetal Medicine, Chiba, Japan (GRID:grid.411321.4) (ISNI:0000 0004 0632 2959)
6 Memorial Sloan Kettering Cancer Center, Department of Pathology and Laboratory Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)




